# Nexviazyme

NDC: 58468-0426
Generic name: avalglucosidase alfa-ngpt
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210806

FDA application: BLA761194

## Active ingredients

- AVALGLUCOSIDASE ALFA: 100 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0426"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0426
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80eb3c9c-01d3-44fe-90ef-81df101b954d